Search | IOVS | ARVO Journals

Showing 1 – 20 of 132

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Are we doing better? Impact of treatment paradigm change on neovascular age-related macular degeneration treatment outcomes over the past decade. A big data analysis.

Roy Schwartz; Alasdair Warwick; Abraham Olvera-Barrios; Maria Pikoula; Aaron Y Lee; Spiros Denaxas; Paul Taylor; Catherine Egan; Usha Chakravarthy; Peck Lin Lip; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):344. doi:

ARVO Annual Meeting Abstract June 2021

Visual acuity and intraocular pressure measurements: Is there a systemic bias in measurement? A UK multicentre study

Taha Soomro; Darren Thomas; Roy Schwartz; Alasdair Warwick; Abraham Olvera-Barrios; Gus Gazzard; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3501. doi:

ARVO Annual Meeting Abstract June 2021

The effect of diabetic macular edema treatment on diabetic retinopathy progression: Real-world data from 27 UK hospitals

Abdulrahman H. Alsaedi; Tjebo Herren; Darren Thomas; Paul Taylor; Catherine Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1110. doi:

ARVO Annual Meeting Abstract June 2021

Effects of smoking, alcohol, blood pressure, body mass index and glycaemic risk factors on advanced age-related macular degeneration: a mendelian randomisation study

Valerie Kuan; Alasdair Warwick; Aroon Hingorani; Adnan Tufail; International AMD Genomics Consortium (IAMDGC) .; Valentina Cipriani; Stephen Burgess; Reecha Sofat

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1503. doi:

ARVO Annual Meeting Abstract June 2021

Emulated trial comparing the effectiveness of Bevacuzimab vs Aflibercept using an external control arm

Paul Taylor; Darren Thomas; Aaron Y Lee; Philipp L. Mueller; Roy Schwartz; Abraham Olvera-Barrios; Alasdair Warwick; Praveen J Patel; Tjebo Herren; Catherine Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):454. doi:

ARVO Annual Meeting Abstract June 2021

Outcomes and risk of reactivation of myopic CNV: Multi-Centre Study with long term follow up

Moawiya Alshunnar; Roy Schwartz; Alasdair Warwick; Abraham Olvera-Barrios; Maria Pikoula; Darren Thomas; Aaron Y Lee; Spiros Denaxas; Catherine Egan; Usha Chakravarthy; Peck Lin Lip; Paul Taylor; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):653. doi:

ARVO Annual Meeting Abstract June 2021

Prevalence and Associations of Dome-Shape Macular Configuration – A Macular Curvature Study on UK Biobank data

Philipp L. Mueller; Yuka Kihara; Abraham Olvera-Barrios; Roy Schwartz; Alasdair Warwick; Catherine Egan; Katie M. Williams; Aaron Y Lee; Adnan Tufail; UK Biobank Eyes and Vision Consortium

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1920. doi:

ARVO Annual Meeting Abstract June 2021

Foveal curvature and its associations in UK Biobank participants

Abraham Olvera-Barrios; Yuka Kihara; Alasdair Warwick; Philipp L. Mueller; Catherine Egan; Katie Williams; Aaron Y Lee; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2304. doi:

Articles March 2021

Reliability of Retinal Pathology Quantification in Age-Related Macular Degeneration: Implications for Clinical Trials and Machine Learning Applications

PDF

Philipp L. Müller; Bart Liefers; Tim Treis; Filipa Gomes Rodrigues; Abraham Olvera-Barrios; Bobby Paul; Narendra Dhingra; Andrew Lotery; Clare Bailey; Paul Taylor; Clarisa I. Sánchez; Adnan Tufail
TAGS: age-related macular degeneration, machine learning, pathology, reliability, drusen, diagnostic imaging
Trans. Vis. Sci. Tech.. 2021; 10(3):4. doi: https://doi.org/10.1167/tvst.10.3.4

Includes: Supplemental Content

Articles December 2020

Structure–Function Analysis in Macular Drusen With Mesopic and Scotopic Microperimetry

PDF

Giovanni Montesano; Giovanni Ometto; Bethany E. Higgins; Costanza Iester; Konstantinos Balaskas; Adnan Tufail; Usha Chakravarthy; Ruth E. Hogg; David P. Crabb

Trans. Vis. Sci. Tech.. 2020; 9(13):43. doi: https://doi.org/10.1167/tvst.9.13.43

ARVO Annual Meeting Abstract June 2020

Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness

Philipp Mueller; Tim Treis; Maximilian Pfau; Simona Degli Esposti; Abdulrahman Alsaedi; Peter Maloca; Konstantinos Balaskas; Andrew Webster; Catherine A Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1057. doi:

ARVO Annual Meeting Abstract June 2020

Diabetic retinopathy prevalence and associations in a large population-based cohort: a three-way data linkage study

Alasdair Warwick; Robert Luben; Tjebo Heeren; Abraham Olvera Barrios; Sharon Yu Lin Chua; Paul J Foster; Adnan Tufail; Catherine A Egan; Anthony P Khawaja

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3833. doi:

ARVO Annual Meeting Abstract July 2019

Seasonal variation of first presentation with neovascular age-related macular degeneration

Roy Schwartz; Tjebo Heeren; Adnan Tufail; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):62. doi:

Articles June 2019

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System

PDF

Mali Okada; Tjebo F. C. Heeren; Pádraig J. Mulholland; Peter M. Maloca; Marketa Cilkova; Vincent Rocco; Marcus Fruttiger; Catherine A. Egan; Roger S. Anderson; Adnan Tufail
TAGS: angiogram, diagnostic imaging, optics, mosaicism
Trans. Vis. Sci. Tech.. 2019; 8(3):54. doi: https://doi.org/10.1167/tvst.8.3.54

Includes: Multimedia, Supplemental Content

Special Issue October 2018

Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

PDF

Rohit Varma; Eric H. Souied; Adnan Tufail; Elizabeth Tschosik; Daniela Ferrara; Jiameng Zhang; David Silverman; Chantal Dolan; Neil M. Bressler
TAGS: age-related macular degeneration, atrophy, reading speed, reading (activity), eye
Invest. Ophthalmol. Vis. Sci.. 2018; 59(4):AMD195-AMD201. doi: https://doi.org/10.1167/iovs.18-24238

ARVO Annual Meeting Abstract July 2018

Ranibizumab and Aflibercept: Baseline and 12-month visual outcomes of patients at a large tertiary ophthalmic hospital

Siegfried K Wagner; Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Thushanthi Ramakrishnan; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):815. doi:

ARVO Annual Meeting Abstract July 2018

Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital

Reena Chopra; Siegfried K Wagner; Katrin Fasler; Karsten Ulrich Kortuem; Nikolas Pontikos; Farid Afshar; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Praveen Patel; Adnan Tufail; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):816. doi:

ARVO Annual Meeting Abstract July 2018

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Siegfried K Wagner; Laxmi Raja; Hasaneen Al Janabi; Thushanthi Ramakrishnan; GABRIELLA CLAIRE PRESTON; Konstantinos Balaskas; Adnan Tufail; Praveen Patel; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):826. doi:

ARVO Annual Meeting Abstract July 2018

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; NIKOLAS PONTIKOS; Siegfried Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):838. doi:

ARVO Annual Meeting Abstract July 2018

Mortality of patients under anti-VEGF therapy at a large tertiary ophthalmic hospital

GABRIELLA CLAIRE PRESTON; NIKOLAS PONTIKOS; Farid Afshar; Reena Chopra; Siegfried K Wagner; Katrin Fasler; Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Adnan Tufail; Konstantinos Balaskas; Praveen Patel; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1469. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Are we doing better? Impact of treatment paradigm change on neovascular age-related macular degeneration treatment outcomes over the past decade. A big data analysis.

Visual acuity and intraocular pressure measurements: Is there a systemic bias in measurement? A UK multicentre study

The effect of diabetic macular edema treatment on diabetic retinopathy progression: Real-world data from 27 UK hospitals

Effects of smoking, alcohol, blood pressure, body mass index and glycaemic risk factors on advanced age-related macular degeneration: a mendelian randomisation study

Emulated trial comparing the effectiveness of Bevacuzimab vs Aflibercept using an external control arm

Outcomes and risk of reactivation of myopic CNV: Multi-Centre Study with long term follow up

Prevalence and Associations of Dome-Shape Macular Configuration – A Macular Curvature Study on UK Biobank data

Foveal curvature and its associations in UK Biobank participants

Reliability of Retinal Pathology Quantification in Age-Related Macular Degeneration: Implications for Clinical Trials and Machine Learning Applications

Structure–Function Analysis in Macular Drusen With Mesopic and Scotopic Microperimetry

Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness

Diabetic retinopathy prevalence and associations in a large population-based cohort: a three-way data linkage study

Seasonal variation of first presentation with neovascular age-related macular degeneration

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System

Maximum Reading Speed in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Ranibizumab and Aflibercept: Baseline and 12-month visual outcomes of patients at a large tertiary ophthalmic hospital

Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital

One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Mortality of patients under anti-VEGF therapy at a large tertiary ophthalmic hospital

To View More...

You must be signed into an individual account to use this feature.